Get started
Author

Kazunori Murai

Observed names: K Murai, K. Murai, KAZUNORI MURAI, Kazunori Murai, Murai, Kazunori
Observed institutions: Fukushima Medical University, Iwate University, Iwate Medical University, Aomori Prefectural Central Hospital, Iwate Prefectural Central Hospital, Morioka Red Cross Hospital
ORCID: 0000-0002-7353-3495
Observed ORCID: 0000-0002-7353-3495
OpenAlex ID: A5086856159
Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial
2015 · Jun Imagawa, Hideo Tanaka, et al. · The Lancet Haematology · 319
Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment
2018 · Masaya Okada, Jun Imagawa, et al. · Clinical Lymphoma Myeloma & Leukemia · 120
Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial
2020 · Shinya Kimura, Jun Imagawa, et al. · The Lancet Haematology · 112
Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial
2021 · Kazunori Murai, Hiroshi Ureshino, et al. · The Lancet Haematology · 71
PDF
Pharmacokinetics and pharmacodynamics of dasatinib in the chronic phase of newly diagnosed chronic myeloid leukemia
2015 · the Inter-Michinoku Dasatinib Study Group (IMIDAS), Yoji Ishida, et al. · European Journal of Clinical Pharmacology · 51
Platelet demand modulates the type of intravascular protrusion of megakaryocytes in bone marrow
2014 · Shugo Kowata, Sumio Isogai, et al. · Thrombosis and Haemostasis · 48
Clinical and Biological Significance of CD56 Antigen Expression in Acute Promyelocytic Leukemia
2004 · Shigeki Ito, Yoji Ishida, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 43
Deguelin suppresses cell proliferation via the inhibition of survivin expression and STAT3 phosphorylation in HTLV-1-transformed T cells
2009 · Shigeki Ito, Tatsuo Oyake, et al. · Leukemia Research · 33
Causes of macrocytic anemia among 628 patients: mean corpuscular volumes of 114 and 130 fL as critical markers for categorization
2016 · Natsuko Takahashi, Junichi Kameoka, et al. · International Journal of Hematology · 31
Bortezomib induces thrombocytopenia by the inhibition of proplatelet formation of megakaryocytes
2014 · Kazunori Murai, Shugo Kowata, et al. · European Journal Of Haematology · 29
Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial
2015 · Tatsuo Oyake, Shugo Kowata, et al. · European Journal Of Haematology · 22
Clinical significance of high-Km 5′-nucleotidase (cN-II) mRNA expression in high-risk myelodysplastic syndrome
2007 · Keijiro Suzuki, Takeshi Sugawara, et al. · Leukemia Research · 19
Evaluation of the safety and efficacy of recombinant soluble thrombomodulin for patients with disseminated intravascular coagulation associated with acute leukemia: multicenter prospective study by the Tohoku Hematology Forum
2017 · On behalf of the Tohoku Hematology Forum, Hisayuki Yokoyama, et al. · International Journal of Hematology · 18
Safety and feasibility of high-dose ranimustine (MCNU), carboplatin, etoposide, and cyclophosphamide (MCVC) therapy followed by autologous stem cell transplantation for malignant lymphoma
2012 · Yoshihiro Kameoka, Naoto Takahashi, et al. · International Journal of Hematology · 15
T-cell prolymphocytic leukemia in Japan: is it a variant?
2012 · Junichi Kameoka, Naoto Takahashi, et al. · International Journal of Hematology · 15
Factor XII Ofunato: Lys346Asn mutation associated with blood coagulation factor XII deficiency causes impaired secretion through a proteasome-mediated degradation
2009 · Keijiro Suzuki, Kazunori Murai, et al. · Thrombosis Research · 15
KIR3DL1-HLA-Bw status in CML is associated with achievement of TFR: the POKSTIC trial, a multicenter observational study
2024 · Hiroshi Ureshino, Yasunori Ueda, et al. · Blood Neoplasia · 14
Clinicopathological characteristics of malignant lymphoma in patients with hepatitis C virus infection in the Tohoku district in Eastern Japan
2016 · Katsushi Tajima, Naoto Takahashi, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 14
High prevalence of diffuse large B‐cell lymphoma in occult hepatitis B virus‐infected patients in the Tohoku district in Eastern Japan
2016 · Katsushi Tajima, Naoto Takahashi, et al. · Journal of Medical Virology · 14
Quantitative assessment of contaminating tumor cells in autologous peripheral blood stem cells of B-cell non-Hodgkin lymphomas using immunoglobulin heavy chain gene allele-specific oligonucleotide real-time quantitative–polymerase chain reaction
2003 · Akiko Yashima, Chihaya Maesawa, et al. · Leukemia Research · 14
A combination chemotherapy with low doses of cytarabine and etoposide for high risk myelodysplastic syndromes and their leukemic stage: A pilot study
1996 · Shin-ichiro Kuriya, Kazunori Murai, et al. · Cancer · 14
PDF
Safety and efficacy of high-dose ranimustine (MCNU) containing regimen followed by autologous stem cell transplantation for diffuse large B-cell lymphoma
2018 · Yoshihiro Kameoka, Tomoaki Akagi, et al. · International Journal of Hematology · 13
Successful treatment of two patients with primary cardiac malignant lymphoma.
1999 · S Enomoto, T Abo, et al. · PubMed · 13
Flow cytometric analysis of aberrant antigen expression of blasts using CD45 blast gating for minimal residual disease in acute leukemia and high-risk myelodysplastic syndrome
2001 · Shigeki Ito, Yoji Ishida, et al. · Leukemia Research · 12
Five-year interim analysis of J-SKI: an observational study of TKI discontinuation in patients with CML in Japan
2026 · Naoto Takahashi, Shinya Kimura, et al. · International Journal of Hematology · 11
PDF
Works count: 131
Citation count: 1,244
H-index: 15
I10-index: 30
Year
Topic
Type